(Press-News.org) A new scientific review of 148 studies enrolling over 4.3 million adult chronic pain patients treated with prescription opioid painkillers has found that nearly one in ten patients experiences opioid dependence or opioid use disorder and nearly one in three shows symptoms of dependence and opioid use disorder. This review provides a more accurate -- and more concerning -- rate of opioid misuse than has previously been calculated. It was conducted by researchers at the University of Bristol, funded by the National Institute for Health and Care Research (NIHR), and appears in the scientific journal Addiction.
Companies like Oxycontin manufacturer Purdue Pharma have claimed that fewer than 1% of opioid prescriptions result in problems for patients. This new review makes clear that such claims greatly understate the risk of opioid misuse and addiction.
The researchers divided the 148 studies into four general categories, depending on how the studies defined problematic opioid use:
dependence and opioid use disorder: 43 studies that identified problematic opioid use through diagnostic codes (formal diagnoses using precise definitions);
signs and symptoms of dependence and opioid use disorder: 44 studies that looked for behaviours indicating dependence and opioid use disorder, such as craving, tolerance, or withdrawal, without use of specific diagnostic codes;
aberrant behaviour: 76 studies that looked for inappropriate or concerning behaviour, such as seeking early refills, repeated dose escalations, or frequently lost prescriptions; and
at risk of dependence and opioid use disorder: 8 studies that looked for characteristics that might increase the risk of developing opioid dependence or opioid use disorder in the future; however, the characteristics do not fall within previous categories of aberrant behaviour or dependence and opioid use disorder.
Some studies reported multiple results within the same participants using different measurement criteria, so the sum of the number of studies in each category equals more than 148. The prevalence (frequency) of problematic opioid use for each category was:
Dependence and opioid use disorder: 9.3%, or nearly 1 in 10 patients.
Signs and symptoms of dependence and opioid use disorder: 29.6%, nearly 1 in 3 patients.
Aberrant behaviour: 22%, more than 1 in 5 patients.
At risk of dependence and opioid use disorder: 12.4%, nearly 1 in 8 patients.
Lead author Kyla Thomas, Professor of Public Health Medicine at the University of Bristol, explains, “Clinicians and policy makers need a more accurate estimate of the prevalence of problematic opioid use in pain patients so that they can gauge the true extent of the problem, change prescribing guidance if necessary, and develop and implement effective interventions to manage the problem. Knowing the size of the problem is a necessary step to managing it.”
The studies in this review were predominantly from North American research and high-income countries. One hundred and six of the 148 studies were conducted between 2010 and 2021; the oldest study was from 1985. Study size ranged from 15 to 2,304,181 patients. Due to the high heterogeneity of the studies, these findings should be interpreted with caution.
-- Ends –
For editors:
This Open Access paper is available on the Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1111/add.16616) or you may request a copy from Jean O’Reilly, Editorial Manager, Addiction, jean@addictionjournal.org.
To speak with lead author Professor Kyla Thomas (Professor of Public Health Medicine), please contact her at the University of Bristol (UK) by e-mail (Kyla.Thomas@bristol.ac.uk).
For further information or to arrange an interview with Professor Kyla Thomas please contact Joanne Fryer [Mon to Wed], email joanne.fryer@bristol.ac.uk, mobile: +44 (0)7747 768805 or Caroline Clancy [Wed to Fri], email caroline.clancy@bristol.ac.uk, mobile: +44 (0)7776 170238 in the University of Bristol Press Office.
Full citation for article: Thomas KH, Dalili MN, Cheng H-Y, Dawson S, Donnelly N, Higgins JPT, and Hickman M. Prevalence of problematic pharmaceutical opioid use in patients with chronic non cancer pain: a systematic review and meta-analysis. Addiction. 2024. DOI: 10.1111/add.16616
Primary funding: National Institute for Health and Care Research: PDF-2017-10-068
Declaration of interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: KT reports financial support from the National Institute for Health and Care Research (NIHR) for this study.
Addiction (www.addictionjournal.org) is a monthly international scientific journal publishing peer-reviewed research reports on alcohol, substances, tobacco, gambling, editorials, and other debate pieces. Owned by the Society for the Study of Addiction, it has been in continuous publication since 1884.
The mission of the National Institute for Health and Care Research (NIHR) (https://www.nihr.ac.uk/) is to improve the health and wealth of the nation through research. We do this by:
Funding high quality, timely research that benefits the NHS, public health and social care;
Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
Funding applied global health research and training to meet the needs of the poorest people in low and middle income countries.
NIHR is funded by the Department of Health and Social Care. Its work in low and middle income countries is principally funded through UK international development funding from the UK government.
Please note the following resources for chronic pain and opioids:
NICE guidance on chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: https://www.nice.org.uk/guidance/ng193/chapter/Recommendations#managing-chronic-primary-pain
Opioids Aware: a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain: https://www.fpm.ac.uk/opioids-aware
How to get NHS help for your pain: https://www.nhs.uk/live-well/pain/how-to-get-nhs-help-for-your-pain/
National Institute on Drug Abuse information on opioids: https://nida.nih.gov/research-topics/opioids
CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022): https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm END
Prescription painkiller misuse and addiction are widespread in chronic pain patients
2024-08-08
ELSE PRESS RELEASES FROM THIS DATE:
When mammoths roamed Vancouver Island: SFU and Royal BC Museum delve into beasts’ history in our region
2024-08-07
Mammoths, the massive pre-historic ice age cousins of the modern-day elephant, have always been understood to have inhabited parts of British Columbia, but the question of when has always been a bit woolly.
Now, a new study from Simon Fraser University has given scientists the clearest picture yet when the giant mammals roamed Vancouver Island.
As part of SFU researcher Laura Termes’ PhD and published earlier this month in the Canadian Journal of Earth Sciences, the study examined 32 suspected mammoth samples collected on Vancouver Island. Of those samples, just 16 ...
Ochsner Health welcomes Mary Claire Curet, MD, as first Ochsner Physician Scholar
2024-08-07
Lafayette, La. – Ochsner Health is excited to announce that Mary Claire Curet, MD, is joining the team at St. Martinville Family Medicine, an Ochsner primary care practice. Dr. Curet, a native of New Iberia, is the first Ochsner Physician Scholar and brings a wealth of knowledge and a deep commitment to her community.
“We are thrilled to welcome Dr. Curet to the Ochsner family,” said Leonardo Seoane, MD, Founding Dean of Xavier Ochsner College of Medicine and Executive Vice President and Chief Academic Officer for Ochsner Health. “Her dedication and passion for primary care, particularly in underserved ...
Discovering how plants make life-and-death decisions
2024-08-07
Researchers at Michigan State University have discovered two proteins that work together to determine the fate of cells in plants facing certain stresses.
Ironically, a key discovery in this finding, published recently in Nature Communications, was made right as the project's leader was getting ready to destress.
Postdoctoral researcher Noelia Pastor-Cantizano was riding a bus to the airport to fly out for vacation, when she decided to share a promising result she had helped gather a day earlier.
“I didn’t want to wait ten days until I came back to send it. It took almost two years to get there,” said Pastor-Cantizano, who then worked ...
National Academies progress report: Health disparities
2024-08-07
Irvine, Calif., Aug. 7, 2024 — From costing society an estimated $11 trillion to hindering new discoveries in medicine and preventing access to effective interventions, underrepresentation of women, older adults and minorities in clinical research has several significant consequences, according to recent analyses commissioned by the National Academies of Sciences, Engineering and Medicine.
Jonathan Watanabe, UC Irvine professor of clinical pharmacy practice and director of the campus’s Center for Data-Driven Drugs Research and Policy, ...
Lemurs use long-term memory, smell, and social cues to find food
2024-08-07
How do foraging animals find their food? A new study by New York University researchers shows that lemurs use smell, social cues, and long-term memory to locate hidden fruit—a combination of factors that may have deep evolutionary roots.
“Our study provides evidence that lemurs can integrate sensory information with ecological and social knowledge, which demonstrates their ability to consider multiple aspects of a problem,” said anthropologist Elena Cunningham, a clinical professor of molecular pathobiology at NYU College of Dentistry and the lead author of the study, published in the International Journal of Primatology.
Animals rely on ...
New research challenges conventional wisdom on wet surface adhesion
2024-08-07
Scientists at the University of Akron and the University of Pittsburgh have overturned long-held assumptions in new research that finds water can be a help for adhesion.
Dr. Ali Dhinojwala, distinguished W. Gerald Austen Endowed Chair and H.A. Morton Professor at The University of Akron’s School of Polymer Science and Polymer Engineering, lead a team whose significant breakthrough — that water can unexpectedly enhance adhesion under controlled conditions — was published Aug. 7 in Science Advances.
The implications of this research are profound, particularly in biomedical applications ...
Newly published report outlines findings from first archaeology project in space
2024-08-07
The first-ever archeological survey in space has provided new insights into how astronauts use and adapt their living space on the International Space Station, which could influence the design of new space stations after the ISS is decommissioned.
Findings from the research team behind the International Space Station Archaeological Project (ISSAP) were published today in the journal PLOS ONE. Archaeologist Justin Walsh of Chapman University is available to discuss the discoveries of the team’s first on-orbit project, the Sampling Quadrangle Assemblages Research Experiment (SQuARE).
While Earth-bound archaeologists dig one-meter squares to understand ...
Memory loss in aging and dementia: Dendritic spine head diameter predicts memory in old age
2024-08-07
BIRMINGHAM, Ala. – Over the course of life, memory fades with varying degrees, robbing older people of the ability to recollect personal experiences. This progressive, nearly inevitable process has long been hypothesized as a consequence of nature’s removal of dendritic spines, a key component of synapses, from brain neurons as they age.
A study published in Science Advances led by researchers at the University of Alabama at Birmingham and Rush University Medical Center, Chicago, Illinois, now provides evidence that the preservation of past life experiences ...
Birmingham host to investigational treatment trial which could improve outcomes of pregnancies affected by severe haemolytic disease
2024-08-07
Pregnant mothers have taken part in a clinical study (the UNITY trial) in Birmingham, which has found that nipocalimab, an investigational, fully human, monoclonal antibody, has the potential to improve the survival rate of unborn babies with rare, early-onset fetal anaemia, as a result of haemolytic disease of the fetus and newborn (EOS-HDFN).
The study investigated pregnancies complicated by severe EOS-HDFN (RhD (D) or Kell (K) alloimmunized pregnant individuals with singleton pregnancies) and evaluated the effects of nipocalimab at weekly intervals from 14-35 ...
Drug trial for rare fetal blood disease shows promise for less invasive approach
2024-08-07
AUSTIN, Texas — Data from a new investigational drug that could alter the standard treatment for a rare blood disease suggests it has the potential to delay or prevent anemia and the need for intrauterine blood transfusions in babies who are at high risk for the condition, known as Hemolytic Disease of the Fetus and Newborn (HDFN). Results of the Phase 2 clinical trial of the drug nipocalimab were published today in The New England Journal of Medicine.
HDFN is a serious condition in which the blood types of the mother and her fetus do not match, potentially causing life-threatening anemia in the baby. The current ...